|
 |
 |
|
News bites: Counterfeit drugs, food safety and more
A second case of the counterfeit cancer drug Avastin reaching the U.S. market is focusing attention on the obscure overseas suppliers that are involved in shipping the medicines to U.S. doctors, The Wall Street Journal reports.
Federal food safety inspectors criticized a proposal by the Agriculture Department to allow private companies to take over the inspections at poultry plants, The New York Times reports.
Mississippi passed a bill that will require any doctor performing abortions in the state to be a board-certified OB-GYN with admitting privileges at a local hospital, Kaiser Health News reports.
Repealing President Obama's healthcare reform law would disproportionately hurt the credit ratings of for-profit hospitals, Modern Healthcare reports.
The chairman of the European Medicines Agency's main committee for approving new drugs resigned suddenly on Wednesday, Reuters reports.
